ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies

  Real-world data (RWD) is transforming colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

• Consolidating Access Into A Single Platform: A Site CEO's Perspective

  By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.

• The Vision That's Reimagining Clinical Development

  Learn how Medable is working to turn fragmented, sequential processes into continuous progress, accelerating the path from protocol to patient for our clients.

• Avoiding Vaporware – Even More Questions To Ask eClinical Platform Providers

  For a platform that aligns with the demands of modern clinical research, delve into these considerations to ensure your choice supports your study’s success.

• Reclaiming Your Time: How Sponsors Can Save Thousands Of Hours With Agentic AI

  Reimagine the clinical trial lifecycle by automating slow, manual workflows, removing barriers in the clinical process, and introducing new ways to achieve R&D goals like never before.

• Nevro Eliminates Majority Of Source Data Verification With ePRO And EDC

  Read how a global medical device company was able to unlock new efficiencies by implementing data collection via electronic patient-reported outcome assessments.

• The Win-Win Wth Virtual Visits – Better Experiences, Better Data

  Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.

• A New Take On The Evolving Role Of AI In Clinical Trials

  Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• EU Annex 11: How To Stay Compliant

  EU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.